PFO
ETRM

Pathstone Family Office’s EnteroMedics Inc. ETRM Stock Holding History

Pathstone Family Office’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2
Closed -$3K – 340
2014
Q3 		$3K Hold
2
– – 0.01% 284
2014
Q2 		$4K Hold
2
– – 0.01% 121
2014
Q1 		$5K Hold
2
– – 0.01% 131
2013
Q4 		$5K Buy
+2
New +$3.22K 0.01% 165

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Pathstone Family Office's ETRM Position: Q4 2014 in Review

Pathstone Family Office sold out of EnteroMedics Inc. (ETRM) in Q4 2014, closing a stake of 2 shares — an estimated $3K sold.

Pathstone Family Office first reported a position in ETRM in Q4 2013 and held it in 4 quarters. The position peaked at $5K in Q1 2014. 46 funds tracked by Wall St. Rank hold ETRM as of Q4 2014.

  • Pathstone Family Office reported no remaining EnteroMedics Inc. position as of Q4 2014 after selling out during the quarter.
  • Pathstone Family Office sold 2 EnteroMedics Inc. shares in Q4 2014, an estimated $3K.
  • Pathstone Family Office first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 4 quarters.
  • Pathstone Family Office's EnteroMedics Inc. position peaked at $5K in Q1 2014.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2014.

Based on Pathstone Family Office's 13F filing for Q4 2014, filed 6 Feb 2015.